Gene Editing Following third dose of BNT162b2, adverse events increased in those with prior COVID-19 Posted on February 23, 2023 by Editorial Staff Previous SARS-CoV-2 infection exacerbates the adverse reactions experienced after receipt of the third booster dose. Share on FacebookTweetFollow us Editorial Staff NQO2 gene as a novel potential target in Parkinson’s disease Study highlights COVID-19 vaccine safety among children